The spectrum of autoimmune thyroid disease in the short to medium term following interferon-therapy for chronic hepatitis C

International Journal of Endocrinology

Volumn 2009, Issue , 2009, Pages

  Tran, Huy A ^a   Reeves, Glenn E M ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CARBIMAZOLE; LIOTHYRONINE; PROPRANOLOL; RIBAVIRIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CASE REPORT; DRUG TREATMENT FAILURE; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; GRAVES DISEASE; HEPATITIS C; HUMAN; HYPOTHYROIDISM; LETHARGY; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; SINUS TACHYCARDIA; THYROTOXICOSIS; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 78751652478     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2009/241786     Document Type: Article

References (25)

1. Barrre X., Valeix P., Preziosi P., Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort (Pubitemid 30169682)
2. Bohbot N. L., Young J., Orgiazzi J., Interferon- -induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves disease European Journal of Endocrinology 2006 154 3 367 372
3. Carella C., Mazziotti G., Morisco F., Long-term outcome of interferon- -induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment The Journal of Clinical Endocrinology Metabolism 2001 86 5 1925 1929 (Pubitemid 32472899)
4. Doi F., Kakizaki S., Takagi H., Long-term outcome in interferon- -induced autoimmune thyroid disorders in chronic hepatitis C Liver International 2005 25 2 242 246
5. Tong M. J., Reddy K. R., Lee W. M., Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial Hepatology 1997 26 3 747 754 (Pubitemid 27392369)
6. Wong V., Fu A. X.-L., George J., Cheung N. W., Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis Clinical Endocrinology 2002 56 6 793 798 (Pubitemid 34785912)
7. Tran H. A., Reeves G. E. M., Jones T. I., The natural history of interferon- 2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection QJM 2009 102 2 117 122
8. Cargnel A., Gubertini G., Magnani C., Bosis S., Colombo F., Clerici M., Immune response in chronic hepatitis C-infected patients undergoing interferon treatment Hepatology 1999 30 2 584 585 (Pubitemid 29357533)
9. Ridgway E. C., Tomer Y., McLachlan S. M., Update in thyroidology The Journal of Clinical Endocrinology Metabolism 2007 92 10 3755 3761
10. Corssmit E. P. M., de Metz J., Sauerwein H. P., Romijn J. A., Biologic responses to IFN- administration in humans Journal of Interferon and Cytokine Research 2000 20 12 1039 1047 (Pubitemid 32015242)
11. Lloyd A. R., Jagger E., Post J. J., Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection Immunology and Cell Biology 2007 85 1 24 32 (Pubitemid 46067318)
12. Gowans E. J., Distribution of markers of hepatitis C virus infection throughout the body Seminars in Liver Disease 2000 20 1 85 102 (Pubitemid 30421411)
13. Roti E., Minelli R., Giuberti T., Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha American Journal of Medicine 1996 101 5 482 487 (Pubitemid 126335968)
14. Boettler T., Spangenberg H. C., Neumann-Haefelin C., T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection Journal of Virology 2005 79 12 7860 7867 (Pubitemid 40756821)
15. McLachlan S. M., Nagayama Y., Pichurin P. N., The link between Graves disease and Hashimotos thyroiditis: a role for regulatory T cells Endocrinology 2007 148 12 5724 5733 (Pubitemid 350146191)
16. de Andrs C., Aristimuo C., Bartolom M., Clinical response to interferon- -1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells. Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study Journal of Neuroimmunology 2009 212 1-2 112 120
17. Nagayama Y., Mizuguchi H., Hayakawa T., Niwa M., McLachlan S. M., Rapoport B., Prevention of autoantibody-mediated Graves-like hyperthyroidism in mice with IL-4, a Th2 cytokine The Journal of Immunology 2003 170 7 3522 3527 (Pubitemid 36359218)
18. Tomer Y., Blackard J. T., Akeno N., Interferon alpha treatment and thyroid dysfunction Endocrinology and Metabolism Clinics of North America 2007 36 4 1051 1066 (Pubitemid 350026253)
19. Mandac J. C., Chaudhry S., Sherman K. E., Tomer Y., The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification Hepatology 2006 43 4 661 672
20. Tran H. A., Hepatitis C infection, treatment regimens, and thyroid function abnormalities Endocrinologist 2007 17 4 231 235 (Pubitemid 47220779)
21. Gelu-Simeon M., Burlaud A., Young J., Pelletier G., Buffet C., Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C World Journal of Gastroenterology 2009 15 3 328 333
22. Demers L. M., Spencer C. A., Laboratory support for the diagnosis and monitoring of thyroid disease. June 2009, http://www.aacc.org/members/nacb/ pages/default.aspx
23. British Society of Gastroenterology, Clinical Guidelines on the management of hepatitis C. June 2009, http://www.bsg.org.uk/pdfworddocs/ clinguidehepc.pdf
24. Dienstag J. L., McHutchison J. G., American gastroenterological association medical position statement on the management of hepatitis C Gastroenterology 2006 130 1 225 230 (Pubitemid 43049855)
25. NIH consensus statement on management of hepatitis C: 2002 NIH Consensus and State-of-the-Science Statements 2002 19 3 1 46